References
- References
- Reynolds PD, Hunter JO. Pharmacotherapy of inflammatory bowel disease. Dig Dis 1993;11:334–42.
- Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990;98:694–702.
- Zijlstra FJ, Garrelds IM, van Dijk APM, Wilson JHP. Experimental colitis in mice: effects of olsalazine on eicosanoid production in colonic tissue. Agents Actions 1992;35:C76–8.
- Axelsson LG, Landström E, Bylund-Fellenius AC. Experimental colitis induced by dextran sulphate sodium in mice: beneficial effects of sulphasalazine and olsalazine. Aliment Pharmacol Ther 1998;12:925–34.
- Elson CO. The basis of current and future therapy for inflammatory bowel disease. Am J Med 1996;100:656–62.
- Giaffer MH, O’Brien CJ, Holdsworth CD. Clinical tolerance to three 5-aminosalicylic acid releasing preparations in patients with inflammatory bowel disease intolerant or allergic to sulphasalazine. Aliment Pharmacol Ther 1992;6:51–9.
- Hanauer SB. Review articles: drug therapy: inflammatory bowel disease. N Engl J Med 1996;334:841–8.
- Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10:81–90.
- Lauritsen K, Laursen LS, Bukhave K, Rask-Madsen J. In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis. Gut 1987;28: 1095–9.
- Nielsen OH, Rask-Madsen J. Mediators of inflammation in chronic inflammatory bowel disease. Scand J Gastroenterol 1996;31 Suppl 216:149–59.
- Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993;14:436–41.
- Friend DR, Phillips S, McLeod A, Tozer TN. Relative antiinflammatory effect of oral dexamethasone-beta-D-glucoside and dexamethasone in experimental inflammatory bowel disease in guinea-pigs. J Pharm Pharmacol 1991;43:353–5.
- Kojouharoff G, Hans W, Obermeier F, Mannel DN, Andus T, Scholmerich J, et al. Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 1997;107:353–8.
- Dieleman LA, Ridwan BU, Tennyson GS, Beagley KW, Bucy RP, Elson CO. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 1994; 107:1643–52.
- Robinson M. Medical therapy of inflammatory bowel disease for the 21st century. Eur J Surg 1998;Suppl:90–8.
- Palmen MJ, Dieleman LA, Soesatyo M, Pena AS, Meuwissen SG, van Rees EP. Effects of local budesonide treatment on the cell-mediated immune response in acute and relapsing colitis in rats. Dig Dis Sci 1998;43:2518–25.
- Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993;69:238–49.
- Parry EW. The role of enteric bacteria in the pathogenesis of fatal cycloheximide intolerance in mice pretreated with dexamethasone, promethazine or nordihydroguaiaretic acid. Inflamm Res 1996;45:354–6.
- Bylund-Fellenius A-C, Axelsson L-G, Midtvedt T. Experimental colitis induced by dextran sulphate in normal and germfree mice. Microb Ecol Health Dis 1994;7:207–15.